Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2022	Mar. 31, 2022
Current assets:
Cash and cash equivalents	$ 303,493	$ 268,695
Short-term investments	563,831	559,984
Accounts receivable, net of allowances of $2,870 and $3,073, respectively	109,637	226,182
Prepaid expenses and other current assets	28,239	29,447
Deferred contract acquisition costs	20,903	24,058
Total current assets	1,026,103	1,108,366
Property and equipment, net	65,501	68,368
Restricted cash	5,775	5,775
Goodwill	163,677	163,677
Intangible assets, net	13,344	15,636
Deferred contract acquisition costs, non-current	6,810	10,463
Lease right-of-use assets	48,093	50,465
Other assets, non-current	5,640	4,916
Total assets	1,334,943	1,427,666
Current liabilities:
Accounts payable	35,260	32,545
Accrued compensation and benefits	35,486	37,023
Other current liabilities	33,985	36,098
Convertible senior notes, current	498,256	0
Deferred revenue	332,882	398,754
Lease liabilities	10,237	11,103
Total current liabilities	946,106	515,523
Convertible senior notes, net	0	497,663
Lease liabilities, non-current	46,218	49,809
Deferred revenue, non-current	74	108
Other liabilities, non-current	17,949	20,173
Total liabilities	1,010,347	1,083,276
Commitments and contingencies (Note 10)
Redeemable non-controlling interest	15,674	21,686
Stockholders’ equity:
Common stock, $0.001 par value; 100,000 shares authorized at June 30, 2022 and March 31, 2022; 67,542 shares and 66,988 shares issued at June 30, 2022 and March 31, 2022, respectively; and 67,282 shares and 66,728 shares outstanding at June 30, 2022 and March 31, 2022, respectively	67	66
Treasury stock - at cost (260 shares)	(263)	(263)
Additional paid-in capital	1,152,613	1,114,221
Accumulated other comprehensive loss	(9,948)	(8,012)
Accumulated deficit	(833,547)	(783,308)
Total stockholders’ equity	308,922	322,704
Total liabilities, redeemable non-controlling interest and stockholders’ equity	$ 1,334,943	$ 1,427,666